Condition: Pancreatic Diseases · Sponsor: University Hospital, Toulouse
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
This description comes directly from the study's public registry record.
Barbara BOURNET, MD · 0561323235 · bournet.b@chu-toulouse.fr
Cindy CANIVET · 05 61 32 20 48 · canivet.c@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| Rangueil hospital | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05824403